{
    "Trade/Device Name(s)": [
        "TD-4277 BLOOD GLUCOSE MONITORING SYSTEM MODEL TD-4277"
    ],
    "Submitter Information": "TaiDoc Technology Corporation",
    "510(k) Number": "K100322",
    "Predicate Device Reference 510(k) Number(s)": [
        "K082169",
        "K090187"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR",
        "JJX"
    ],
    "Summary Letter Date": "June 25, 2010",
    "Summary Letter Received Date": "June 28, 2010",
    "Submission Date": "February 1, 2010",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose Test System",
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood",
        "Venous blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "TD-4277 BLOOD GLUCOSE MONITORING SYSTEM MODEL TD-4277"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Glucose dehydrogenase"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Test Strip",
        "Control Solution",
        "Meter"
    ],
    "Document Summary": "FDA 510(k) summary for TD-4277 Blood Glucose Monitoring System, an electrochemical glucose meter using glucose dehydrogenase for quantitative blood glucose measurement",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from the finger for home and professional use as an aid in diabetes control monitoring; not for diagnosis or neonatal use",
    "fda_folder": "Clinical Chemistry"
}